Phosphatidylcholine Liposomes Down-Modulate CD4 Expression Reducing HIV Entry in Human Type-1 Macrophages

Area of Science:

• Virology
• Immunology
• Cell Biology

Background:

• HIV-1 entry into target cells is a key strategy for combating infection.
• CD4 receptor expression on target cells is crucial for HIV-1 viral entry.

Purpose of the Study:

• To investigate the effect of phosphatidylcholine (PC) liposomes on CD4 receptor expression in macrophages and T cells.
• To elucidate the mechanism by which PC liposomes modulate CD4 expression and its impact on HIV-1 entry.

Main Methods:

• Treatment of human primary macrophages and CD4+ T cells with PC liposomes.
• Analysis of CD4 and CCR5 membrane expression.
• Investigation of the role of Ca2+-independent protein kinase C (PKC) and CD4 serine phosphorylation.
• Assessment of HIV-1 entry in PC liposome-treated cells.

Main Results:

• PC liposomes reduced CD4 receptor expression in human primary macrophages, but not in CD4+ T cells.
• This downregulation was specific to CD4 and did not affect CCR5 expression.
• CD4 downregulation was mediated by Ca2+-independent protein kinase C (PKC), leading to serine phosphorylation, internalization, and degradation of CD4.
• PC liposome-induced CD4 downregulation reduced the entry of R5 tropic HIV-1 in macrophages.

Conclusions:

• PC liposomes effectively reduce HIV-1 entry into human macrophages by downregulating CD4 receptor expression.
• This mechanism offers a potential therapeutic strategy to lower the viral reservoir and impact HIV pathogenesis.